Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): The use of protein analysis as a diagnostic indicator of XLA

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 334-338

  Gaspar, H B ^a   Lester, T ^a   Levinsky, R J ^a   Kinnon, C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bruton's tyrosine kinase; Protein tyrosine kinase; X linked agammaglobulinaemia

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; X LINKED AGAMMAGLOBULINEMIA;

EID: 0031911730     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226-33.
2. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agamma-globulinemia. Cell 1993; 72:279-90.
3. Hashold J, Klaus GG. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur J Immunol 1994; 24:152-7.
4. Matsuda T, Takahashi Tezuka M, Fukada T et al. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 1995; 85:627-33.
5. Sato S, Katagiri T, Takaki S et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994; 180:2101-11.
6. Hashimoto S, Tsukada S, Matsushita M et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 1996; 88:561-73.
7. Hinshelwood S, Lovering RC, Genevier HC, Levinsky RJ, Kinnon C. The protein defective in X-linked agammaglobulinemia. Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked. Eur J Immunol 1995; 25:1113-6.
8. Bradley LA, Sweatman AK, Lovering RC et al. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum Mol Genet 1994; 3:79-83.
9. Gaspar HB, Bradley LA, Katz F et al. Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot. Hum Mol Genet 1995; 4:755-7.
10. Saffran DC, Parolini O, Fitch Hilgenberg ME et al. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med 1994; 330: 1488-91.
11. Conley ME, Rohrer J. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia. Clin Immunol Immunopathol 1995; 76:S192-7.
12. Yel L, Minegishi Y, Coustan-Smith E et al. Mutations in the Mu heavy-chain in patients with agammaglobulinemia. N Engl J Med 1996; 335:1486-93.
13. Kenshi H. PCR-SSCP. A simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods and Applications 1991; 1:34-38.